Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure 5 High-resolution manometry studies performed

Published byAllyson Jennings Modified over 5 years ago

Similar presentations

Presentation on theme: "Figure 5 High-resolution manometry studies performed"— Presentation transcript:

1 Figure 5 High-resolution manometry studies performed
before and after a POEM procedure in a patient with type II achalasia Figure 5 | High-resolution manometry studies performed before and after a POEM procedure in a patient with type II achalasia. Note the fragment of peristalsis proximal to the myotomy (double-headed arrow, extends 5 cm proximal to the EGJ) after per-oral endoscopic myotomy (POEM) that was not evident before myotomy. DCI, distal contractile integral; EGJ, oesophagogastric junction; IRP, integrated relaxation pressure. Kahrilas, P. J. et al. (2017) Advances in the management of oesophageal motility disorders in the era of high-resolution manometry: a focus on achalasia syndromes Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Download ppt "Figure 5 High-resolution manometry studies performed"

Similar presentations

The New Era of Esophageal Motility Disorders

The New Era of Esophageal Motility Disorders
Stephanie G. Worrell, MD, Evan T

Stephanie G. Worrell, MD, Evan T
Figure 3 Low-grade inflammation in FGID

Figure 3 Low-grade inflammation in FGID
Figure 1 Imaging of a depressed intramucosal carcinoma

Figure 1 Imaging of a depressed intramucosal carcinoma
Figure 4 Activation of clopidogrel via cytochrome P450

Figure 4 Activation of clopidogrel via cytochrome P450
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Updates on management of achalasia

Updates on management of achalasia
Figure 5 Lipid droplet consumption

Figure 5 Lipid droplet consumption
Esophageal function testing: Esophageal motility disorders in high-resolution Dustin Carlson, MD, MSCI Assistant Professor of Medicine - Gastroenterology.

Esophageal function testing: Esophageal motility disorders in high-resolution Dustin Carlson, MD, MSCI Assistant Professor of Medicine - Gastroenterology.
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Figure 1 Biosimilar development process

Figure 1 Biosimilar development process
Figure 2 Approach to diagnosis and management of food allergy

Figure 2 Approach to diagnosis and management of food allergy
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Figure 2 Modelling the effect of HCV treatment on reinfection in people who inject drugs Figure 2 | Modelling the effect of HCV treatment on reinfection.

Figure 2 Modelling the effect of HCV treatment on reinfection in people who inject drugs Figure 2 | Modelling the effect of HCV treatment on reinfection.
Figure 1 Definition and concept of ACLF

Figure 1 Definition and concept of ACLF
Figure 2 Switching of biologic agents and biosimilars

Figure 2 Switching of biologic agents and biosimilars
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Similar presentations

Ads by Google